Coromandel International / Q4-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Watch2026-05-15Back to COROMANDELINTERNATIONAL

Revenue

₹6,004 Cr

verified against source

Revenue YoY

19%

reported change

EBITDA

₹494 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q4 FY26: 115 · Watch source sentiment · 2026-05-15Q4 FY26115115
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Coromandel International reported Q4 FY26 consolidated revenue of ₹6,680 crore (+19% YoY) and EBITDA of ₹494 crore (+16% YoY), driven by record fertilizer sales of 4.3 million tons (+7% YoY) and strong crop protection growth. PAT fell to ₹115 crore (vs ₹578 crore) due to exceptional items: prior-year land sale gain of ₹347 crore and current-year impairment of ₹71 crore in the drone business. Full-year revenue hit a record ₹31,827 crore (+30% YoY) with EBITDA of ₹3,232 crore (+23% YoY). The fertilizer segment faced margin compression from surging raw material costs (ammonia ~$840/ton, sulfur ~$800/ton) not fully covered by subsidy. Management expects government relief but declined margin guidance. Crop protection standalone EBITDA margin improved to ~19%. Key risk: delayed subsidy pass-through could pressure H1 FY27 margins.

Colored figures show movement against the previous available record.

Guidance to track

  • Driven by new product launches (6 new products), capacity expansion for key molecule, and aggressive domestic formulation growth.
  • NACL integration and product portfolio changes expected to improve margins from current 6-7%.
  • Project to expand granulation capacity is on track for commissioning by December of this financial year.
  • Planned volume increase from 3.5 lakh tons to support backward integration.

Risks flagged

  • Ammonia and sulfur prices surged ~$840/ton and ~$800/ton respectively, while NBS rates increased only 10%. Government may not provide timely additional subsidy, compressing H1 margins.
  • 80%+ of ammonia and sulfur imports transit via the Strait of Hormuz; ongoing crisis threatens Q2 availability and keeps prices elevated.
  • ₹71 crore impairment taken on Daksha investment due to order execution delays; management is personally driving recovery but no near-term revenue visibility.
  • Despite 60% volume growth, adoption remains slow without policy intervention; farmers continue to prefer subsidized urea and DAP.

Key quotes

  • These are all very extraordinary times very difficult to look at margins at this point of time. It doesn't make sense even to look at either product margin or foss value gap.
  • We are not able to predict anything this time is little uncomfortable for us to put any number on the table let's wait for things to play out before we can completely fair understand it's bit challenging.
  • Our consumption has reached the peak of 4.1 million tons making us the largest player, the highest market share of 17.5% in the phosphotic sector in the country.

Research modules

Go one layer deeper.